Leerink Partners Cuts Price target on Diplomat Pharmacy (DPLO) Following Weak EPS Guide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
After-Hours Stock Movers 02/29: (CRC) (APEI) (CECO) Higher; (RMTI) (DPLO) (OPWR) Lower (more...)
February 29, 2016 6:07 PM ESTRockwell Medical Technologies (NASDAQ: RMTI) 27.6% LOWER; reported Q4 EPS of ($0.12), $0.14 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $19.98 million.
Diplomat Pharmacy (NYSE: DPLO) 25.6% LOWER; reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $987 million versus the consensus estimate of $969.7 million. GUIDANCE: Diplomat Pharmacy sees FY2016 EPS of $0.84-$0.89, versus the consensus of $1.00. Diplomat Pharmacy sees FY2016 revenue of $4.3-4.6... More
Diplomat Pharmacy (DPLO) Tops Q4 EPS by 1c
February 29, 2016 4:16 PM ESTDiplomat Pharmacy (NYSE: DPLO) reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $987 million versus the consensus estimate of $969.7 million.
GUIDANCE:
Diplomat Pharmacy sees FY2016 EPS of $0.84-$0.89, versus the consensus of... More
Trading Radar for 2/29: Curis (CRIS), Lumber Liquidators (LL), Netlist (NLST), TASER Int'l (TASR) Report
February 26, 2016 3:19 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
3D Systems (NYSE: DDD) - consensus EPS $0.03
AMC Entertainment (NYSE: AMC) - consensus EPS $0.40
Acadia Pharma (Nasdaq: ACAD) - consensus loss $0.38
Altisource Residential (NYSE: RESI) - consensus EPS $0.18
Ares Management (Nasdaq: ARES) - consensus EPS $0.29
Arqule (Nasdaq: ARQL) - consensus loss... More
